182 related articles for article (PubMed ID: 16227635)
1. Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma.
Abbaszadegan MR; Raziee HR; Ghafarzadegan K; Shakeri MT; Afsharnezhad S; Ghavamnasiry MR
Int J Gastrointest Cancer; 2005; 36(1):47-54. PubMed ID: 16227635
[TBL] [Abstract][Full Text] [Related]
2. Association of roasting meat intake with the risk of esophageal squamous cell carcinoma of Kazakh Chinese via affecting promoter methylation of p16 gene.
Chen W; Yang C; Yang L; Qi C; Tian S; Han Y; Dou Y; Ma Y; Tian D; Zheng Y
Asia Pac J Clin Nutr; 2014; 23(3):488-97. PubMed ID: 25164462
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas.
Fujiwara S; Noguchi T; Takeno S; Kimura Y; Fumoto S; Kawahara K
Dis Esophagus; 2008; 21(2):125-31. PubMed ID: 18269647
[TBL] [Abstract][Full Text] [Related]
4. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma.
Taghavi N; Biramijamal F; Sotoudeh M; Khademi H; Malekzadeh R; Moaven O; Memar B; A'rabi A; Abbaszadegan MR
BMC Cancer; 2010 Apr; 10():138. PubMed ID: 20388212
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma.
Fukuoka T; Hibi K; Nakao A
Anticancer Res; 2006; 26(5A):3333-5. PubMed ID: 17094449
[TBL] [Abstract][Full Text] [Related]
6. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.
Roth MJ; Abnet CC; Hu N; Wang QH; Wei WQ; Green L; D'Alelio M; Qiao YL; Dawsey SM; Taylor PR; Woodson K
Oncol Rep; 2006 Jun; 15(6):1591-7. PubMed ID: 16685400
[TBL] [Abstract][Full Text] [Related]
7. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma.
Wang J; Sasco AJ; Fu C; Xue H; Guo G; Hua Z; Zhou Q; Jiang Q; Xu B
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):118-25. PubMed ID: 18199718
[TBL] [Abstract][Full Text] [Related]
8. [DNA methylation status of RARβ2 and p16(INK4α) in peripheral blood and tumor tissue in patients with esophageal squamous cell carcinoma].
Wang CC; Mao WM; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):441-5. PubMed ID: 22967446
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area.
Guo XQ; Wang SJ; Zhang LW; Wang XL; Zhang JH; Guo W
J Exp Clin Cancer Res; 2007 Dec; 26(4):587-94. PubMed ID: 18365557
[TBL] [Abstract][Full Text] [Related]
10.
Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
[TBL] [Abstract][Full Text] [Related]
11. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma.
Adams L; Roth MJ; Abnet CC; Dawsey SP; Qiao YL; Wang GQ; Wei WQ; Lu N; Dawsey SM; Woodson K
Cancer Prev Res (Phila); 2008 Oct; 1(5):357-61. PubMed ID: 19137073
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of multiple tumor-related genes associated with DNMT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma.
Li B; Wang B; Niu LJ; Jiang L; Qiu CC
Epigenetics; 2011 Mar; 6(3):307-16. PubMed ID: 21150312
[TBL] [Abstract][Full Text] [Related]
15. [Methylation of p16 and hMLH1 genes in esophageal squamous cell carcinoma and reflux esophagitis].
Wang F; Xie XJ; Piao YS; Liu B; Wang LD
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):537-41. PubMed ID: 22169643
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study.
Fan Z; Qin Y; Zhou J; Chen R; Gu J; Li M; Zhou J; Li X; Lin D; Wang J; Deng D; Wei W
Cancer Med; 2022 Nov; 11(21):4033-4042. PubMed ID: 35352503
[TBL] [Abstract][Full Text] [Related]
18. P21(waf1/cip1) gene polymorphisms and possible interaction with cigarette smoking in esophageal squamous cell carcinoma in northeastern Iran: a preliminary study.
Taghavi N; Biramijamal F; Abbaszadegan MR; Khademi H; Sotoudeh M; Khoshbakht S
Arch Iran Med; 2010 May; 13(3):235-42. PubMed ID: 20433229
[TBL] [Abstract][Full Text] [Related]
19. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
20. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
Hibi K; Taguchi M; Nakayama H; Takase T; Kasai Y; Ito K; Akiyama S; Nakao A
Clin Cancer Res; 2001 Oct; 7(10):3135-8. PubMed ID: 11595706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
